Reduction of Vascular Endothelial Growth Factor A in Human Breast Milk After Intravitreal Injection of Bevacizumab but Not Ranibizumab | Breastfeeding | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.100.128. Please contact the publisher to request reinstatement.
1.
Chang LK, Spaide RF, Brue C, Freund KB, Klancnik JM Jr, Slakter JS. Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration.  Arch Ophthalmol. 2008;126(7):941-94518625940PubMedGoogle ScholarCrossref
2.
Ziemssen F, Zhu Q, Peters S,  et al; Tuebingen Bevacizumab Study Group.  Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study.  Int Ophthalmol. 2009;29(4):213-22418418553PubMedGoogle Scholar
3.
Kim H, Robinson SB, Csaky KG. FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.  Mol Vis. 2009;15:2803-281220019892PubMedGoogle Scholar
4.
Chaparro M, Gisbert JP. Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease.  Curr Pharm Biotechnol. 2011;12(5):765-77321342120PubMedGoogle Scholar
5.
Pepper MS, Baetens D, Mandriota SJ,  et al.  Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.  Dev Dyn. 2000;218(3):507-52410878616PubMedGoogle Scholar
6.
Vuorela P, Andersson S, Carpén O, Ylikorkala O, Halmesmäki E. Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine.  Am J Clin Nutr. 2000;72(5):1196-120111063449PubMedGoogle Scholar
Research Letter
Sep 2012

Reduction of Vascular Endothelial Growth Factor A in Human Breast Milk After Intravitreal Injection of Bevacizumab but Not Ranibizumab

Author Affiliations

Author Affiliations: Department of Ophthalmology, University Eye Hospital Freiburg, Freiburg, Germany.

Arch Ophthalmol. 2012;130(9):1226-1227. doi:10.1001/archophthalmol.2012.112
×